glp-1 medications approved for type 2 diabetes 2025 Pipeline Update: February - Prime Therapeutics GLP-1 Pipeline Update: November 2025

"About 1 in 8 adult Americans has already used GLP-1 drugs

The loss of patent protections, the development of cheaper pill formats, and a focus on the previously discovered health benefits of semaglutide, like prevention of kidney and heart disease which will encourage more coverage from governments and insurers all point to the cost barrier weakening significantly in the near future

: , ,

As this phase of the legal process continues, the judge will decide what discovery documents will be admissible going forward

The result showed that AGEs could increase bone resorption by reducing OC and increasing CTX but liraglutide could significantly decrease AGEs and parathyroid hormone (PTH) in ApoE / mice (Zhang et al., 2019a)

Wegovy is approved for people 12 and older